Chemical Hip Denervation for Inoperable Hip Fracture
Autor: | Philip Peng, Sumire Sasaki, Penelope Sham, Wing-sang Chan, Tony Kwun-Tung Ng, Hon-For Tsui |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
musculoskeletal diseases medicine.medical_specialty Chemical denervation 03 medical and health sciences Nursing care 0302 clinical medicine 030202 anesthesiology medicine Humans Pain Management In patient Adverse effect Aged Retrospective Studies Aged 80 and over Denervation Hip fracture Ethanol Hip Fractures business.industry Nerve Block Retrospective cohort study Middle Aged medicine.disease Surgery Anesthesiology and Pain Medicine Ambulatory Female business Femoral Nerve 030217 neurology & neurosurgery |
Zdroj: | Anesthesia & Analgesia. 130:498-504 |
ISSN: | 0003-2999 |
DOI: | 10.1213/ane.0000000000004172 |
Popis: | BACKGROUND Hip fracture is a challenging geriatric problem for the health care professionals, especially in patients with multiple comorbidities. In patients with inoperable hip fracture secondary to severe comorbid conditions, the pain can lead to significant challenges in nursing care. With the current understanding of the innervation of hip joint, we are now able to perform selective chemical denervation of the articular branches of femoral and obturator nerves to manage the pain associated with inoperable hip fracture. METHODS In this retrospective case series, we analyzed 20 consecutive patients with inoperable hip fracture who received chemical denervation and examined the effect of the denervation on pain and functional outcomes, including the maximally tolerable hip flexion and the ability to sit during their hospital stay. We also assessed the likelihood of being ambulatory as a long-term outcome. RESULTS The movement-related pain was significantly reduced at 10 minutes postprocedure, on postintervention days 1 and 5 (P values of |
Databáze: | OpenAIRE |
Externí odkaz: |